About: vaccines
Europe gives go ahead to market Ebola vaccine
The European Union authorised the marketing of a vaccine against Ebola on Monday (11 November), permitting the first wider commercial use of a protection that has helped stem an outbreak in DR Congo.
Poll: Nearly half of Europeans think vaccines ‘can often produce severe side effects’
85% of EU citizens believe vaccines are an effective way of preventing diseases, but almost half of them think vaccines "can often produce severe side-effects," according to a new Eurobarometer survey.
How Brexit will impact healthcare for our pets and farm animals
Brexit, particularly the prospect of 'no deal', poses a serious threat to animal welfare standards and food security, writes Carel du Marchie Sarvaas.
Combination vaccines: more protection for all with less injections
Combination vaccines represent a substantial outcome of a successful R&D to ease vaccination experience for everyone: children, parents and healthcare professionals while improving the protection of the public against vaccine-preventable diseases.
Health and vaccine research set to lose out from new EU research budget
The European Commission may be planning to hike spending for its flagship research programme, but health and scientific research, particularly into new vaccines, was not one of the winners from the proposal announced on Thursday (7 June).
Expert: Animal health innovations will benefit both farming and society
An innovation-driven approach – ranging from vaccination to other health management solutions and appropriate biosecurity measures – will ensure more sustainable future livestock farming and protection of public health, as animal diseases do not recognise borders, Roxane Feller told EURACTIV.com.
How Italy’s scientific community joined forces and shaped national vaccination plan
If the scientific community sticks together and makes a coordinated effort, it can be very influential in shaping national vaccination plans, Italian professor Paolo Bonanni told EURACTIV.com, citing Italy as a prime example.
Commission could play greater role in harmonising vaccines supply, industry says
The European Commission could play a decisive role in further harmonising the regulatory framework of vaccines and therefore avoid delays in the supply of vaccines in case of shortages or emergencies, Vaccines Europe told EURACTIV.com.
ECDC chief: Bigger social media presence needed to fight anti-vaccines fake news
Public health authorities at EU and national level have started working to “occupy more of the space on social media”, as it is currently almost entirely taken up by people who are against vaccination, Dr Andrea Ammon told EURACTIV.com in an interview.
MEP: Vaccination is a lifelong process, not only for children
Parents have a particular responsibility to protect their children, as they are more vulnerable to infections, but vaccination should be seen as a lifelong approach that applies to adults too, centre-right MEP Renate Sommer told EURACTIV.com.
Health tech bill to kick off busy policy agenda in 2018
The European Commission will propose a new law on Health Technology Assessments to kick off a busy EU health agenda in 2018.
Vaccines boss: Clear privacy rules are needed for electronic immunisation record system
An electronic immunisation record system, which aims to better monitor vaccination among populations, will need clear privacy rules and individuals should be the owners of their own data, Patricia Massetti told EURACTIV.com in an interview. Patricia Massetti is an associate...
Commission backs electronic immunisation record to manage vaccination
The European Commission supports the creation of an electronic immunisation record system that will help EU member states enhance their cross-border cooperation and simultaneously enhance prevention of infectious diseases.
Mimica: We are analysing aid funding gaps left by the US
The EU is analysing the aid funding gap left by Donald Trump’s decision to ban US federal funding for NGOs providing birth control support or abortions in developing countries, Development Commissioner Neven Mimica told EURACTIV.com in an exclusive interview.
The ‘Eurovision of inventors’ and new solutions for protecting the planet
Whether or not Donald Trump is taking part in efforts to protect the planet, inventions and technological progress are filling an important gap and the EU is playing a role bigger than generally assumed, writes Eli Hadzhieva.
Soft drink cold chain delivers vaccines to Africa’s most remote corners
A bright idea turned into reality: vaccines are getting to where they are needed, even in the most remote places in several African countries, thanks to specialised refrigeration support from Coca-Cola.
Romania cuts vaccine exports as measles outbreak takes hold
The European Commission has endorsed Romania’s decision to temporarily suspend exports of measles, mumps and rubella (MMR) vaccine to the rest of the EU, following a serious measles outbreak and dwindling medical stocks. EURACTIV Romania reports.
Innovation and the EU: Fewer apps, more vaccines
Innovation is worthy of support, but European leaders need to focus more on life-saving vaccines rather than the development of more delivery apps, writes Cecile Vernant.
Polio: the disease Nigeria can’t seem to shake
Ridding the world of polio is going to take a little longer than originally expected, writes Stratfor, the Texas-based global intelligence company.
Ebola epidemic reveals gaps in research into diseases of poverty
The Vaccine Alliance has announced that it will fund research into an Ebola vaccine. Without public funding, laboratories often ignore illnesses that affect the poorest patients. EURACTIV France reports.
Sanofi cholesterol drug, GSK malaria shot to get EU okay
Sanofi and Regeneron's new cholesterol drug Praluent could be recommended for approval in Europe as early as this week, along with the world's first malaria vaccine from GlaxoSmithKline.
Drug-resistant TB threatens to kill 75 million people by 2050
Over the next 35 years, multidrug-resistant tuberculosis will kill 75 million people and could cost the global economy a cumulative $16.7 trillion (€15.3 trillion) - the equivalent of the European Union's annual output, a UK parliamentary group said on today (24 March).
Big pharma, NGO square the circle on access to vaccines
SPECIAL REPORT: One would expect a multinational pharmaceutical group and a leading humanitarian NGO to hold radically opposed views on access to vaccines.